Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iTTo in treatment-naive advanced gastric or GEJ adenocarcinoma
NCT04808791Phase 2Completed
- Sponsor
- American Health Staffing Group
- Start
- Oct 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trifluridine + tipiracil in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by American Health Staffing Group. Started Oct 2021; status: completed.
02
Drugs
trifluridine + tipiracil
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT04808791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04808791.